Virtu KCG Holdings’s Acura Pharmaceuticals ACUR Stock Holding History

Virtu KCG Holdings’s Portfolio ACUR Stock Details ACUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-44,565	Closed	-$34K	–	4160
2016 Q4	$34K	Buy	+44,565	New	+$46.6K	﹤0.01%	3172
2016 Q3	–	Sell	-20,449	Closed	-$38K	–	3752
2016 Q2	$38K	Buy	+20,449	New	+$52.8K	﹤0.01%	2728
2015 Q3	–	Sell	-2,712	Closed	-$13K	–	4138
2015 Q2	$13K	Sell	2,712 -1,169	-30%	-$4.86K	﹤0.01%	3219
2015 Q1	$15K	Sell	3,881 -446	-10%	-$1.42K	﹤0.01%	2991
2014 Q4	$10K	Buy	+4,327	New	+$12K	﹤0.01%	3656
2014 Q3	–	Sell	-2,128	Closed	-$12K	–	4377
2014 Q2	$12K	Sell	2,128 -377	-15%	-$2.29K	﹤0.01%	3553
2014 Q1	$18K	Buy	+2,505	New	+$21.8K	﹤0.01%	3440

Other funds holding ACUR

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Virtu KCG Holdings's ACUR Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Acura Pharmaceuticals (ACUR) in Q1 2017, closing a stake of 44,565 shares — an estimated $34K sold.

Virtu KCG Holdings first reported a position in ACUR in Q1 2014 and held it in 7 quarters. The position peaked at $38K in Q2 2016. 3 funds tracked by Wall St. Rank hold ACUR as of Q1 2017.

Virtu KCG Holdings reported no remaining Acura Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
Virtu KCG Holdings sold 44,565 Acura Pharmaceuticals shares in Q1 2017, an estimated $34K.
Virtu KCG Holdings first reported a position in Acura Pharmaceuticals in Q1 2014 and held it in 7 quarters.
Virtu KCG Holdings's Acura Pharmaceuticals position peaked at $38K in Q2 2016.
3 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.